Product

Elezanumab

Aliases

ABT-555

3 clinical trials

2 indications

Indication

Spinal Cord Injury

Indication

Clinical trial

Expanded Access to Elezanumab

Status:

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke

Status: Active (not recruiting), Estimated PCD: 2025-01-29

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Traumatic Cervical Spinal Cord Injury

Status: Active (not recruiting), Estimated PCD: 2025-07-18